3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
8
Pancreatic Neoplasms
6
Uterine Cervical Neoplasms
4
Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
3
Rectal Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Hodgkin Disease
2
Glioma
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Thoracic Neoplasms
1
Thoracic Diseases
1
Spinal Diseases
1
Interventions
fluoroazomycin arabinoside
2
Propofol
2
pimonidazole
1
Tirapazamine
1
Sodium Chloride
1
Sevoflurane
1
Saline Solution
1
Magnetic Resonance Imaging
1
Ketamine
1
Ethiodized Oil
1
Dexmedetomidine
1
Blood Specimen Collection
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
Magnetic Resonance Imaging
×
1 year
×
Clear all
NCT05029258
2026-05-12
Bio-CHECC
University of Manchester
Active not recruiting
30 enrolled